ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+4.9%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(-12%)
Cap. Flow
-$5.8M
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
67.36%
Holding
32
New
2
Increased
10
Reduced
13
Closed
6
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$9.99M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$8.83M |
| 3 |
Soleno Therapeutics
SLNO
|
$2.34M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$2.34M |
| 5 |
Praxis Precision Medicines
PRAX
|
$1.92M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.3M |
| 2 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$3.5M |
| 3 |
Jasper Therapeutics
JSPR
|
$2.62M |
| 4 |
EyePoint Pharmaceuticals
EYPT
|
$2.59M |
| 5 |
89bio
ETNB
|
$2.49M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Context Therapeutics
CNTX
$75.6M
| $708K | 0.64% |
1,157,448
-419,314
| -27% | -$257K |
|
|
27
89bio
ETNB
$1.37B
| – | – |
-317,833
| Closed | -$2.49M |
|
|
28
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-348,000
| Closed | -$2.59M |
|
|
29
Jasper Therapeutics
JSPR
$44.2M
| – | – |
-122,424
| Closed | -$2.62M |
|
|
ALMS
30
Alumis Inc. Common Stock
ALMS
$483M
| – | – |
-445,259
| Closed | -$3.5M |
|
|
CLYM
31
Climb Bio, Inc. Common Stock
CLYM
$165M
| – | – |
-760,225
| Closed | -$1.37M |
|
|
ITCI
32
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-147,750
| Closed | -$12.3M |
|